Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes

Heart Rhythm

Volumn 2, Issue 11 SUPPL. 2, 2005, Pages

  Antzelevitch, Charles ^a,b  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Antiarrhythmia agents; Arrhythmia; Arrhythmogenesis; Arterially perfused wedge; Long QT syndrome; Torsades de pointes; Transmural dispersion of repolarization

Indexed keywords

4 [3 (4 BENZHYDRYL 1 PIPERAZINYL) 2 HYDROXYPROPOXY] 1H INDOLE 2 CARBONITRILE; AMIODARONE; ANTIARRHYTHMIC AGENT; CHROMANOL 293B; CISAPRIDE; DOFETILIDE; DRONEDARONE; ERYTHROMYCIN; ISOPRENALINE; MOXIFLOXACIN; PENTOBARBITAL; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; QUINIDINE; RANOLAZINE; SOTALOL;

ARRHYTHMOGENESIS; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG POTENTIATION; DRUG SAFETY; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HUMAN; LONG QT SYNDROME; NONHUMAN; PREDICTION; PRIORITY JOURNAL; QT DISPERSION; QT PROLONGATION; REENTRY TACHYCARDIA; RELIABILITY; REVIEW; RISK ASSESSMENT; T WAVE; TORSADE DES POINTES;

EID: 27744493604     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2004.09.011     Document Type: Article

References (15)

1. M. Keating D. Atkinson C. Dunn K. Timothy G.M. Vincent M. Leppert Linkage of a cardiac arrhythmia, the long-QT syndrome, and the Harvey ras-1 gene Science 252 1991 704-706
2. A. Ricardo Perez Riera C. Ferreira S.J. Dubner E. Schapachnik Andersen syndrome: The newest variant of the hereditary-familial long QT syndrome Ann Noninvas Electrocardiol 9 2004 175-179
3. C. Antzelevitch W. Shimizu Cellular mechanisms underlying the long QT syndrome Curr Opin Cardiol 17 2002 43-51
4. C. Antzelevitch S. Sicouri S.H. Litovsky A. Lukas S.C. Krishnan J.M. Di Diego G.A. Gintant D.W. Liu Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells Circ Res 69 1991 1427-1449
5. C. Antzelevitch W. Shimizu G.X. Yan S. Sicouri J. Weissenburger V.V. Nesterenko A. Burashnikov J. Di Diego J. Saffitz G.P. Thomas The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart J Cardiovasc Electrophysiol 10 1999 1124-1152
6. R.R. Fenichel M. Malik C. Antzelevitch M. Sanguinetti D.M. Roden S.G. Priori J.N. Ruskin R.J. Lipicky L.R. Cantilena Independent Academic Task Force Drug-induced torsade de pointes and implications for drug development J Cardiovasc Electrophysiol 15 2004 475-495
7. G.X. Yan W. Shimizu C. Antzelevitch Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations Circulation 98 1998 1921-1927
8. S. Sicouri S. Moro S. Litovsky M.V. Elizari C. Antzelevitch Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart J Cardiovasc Electrophysiol 8 1997 1269-1279
9. J.M. van Opstal M. Schoenmakers S.C. Verduyn S.H. de Groot J.D. Leunissen F.F. van Der Hulst M.M. Molenschot H.J. Wellens M.A. Vos Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome Circulation 104 2001 2722-2727
10. W. Shimizu B. McMahon C. Antzelevitch Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsade de pointes in models of acquired and congenital long QT syndrome J Cardiovasc Electrophysiol 10 1999 154-164
11. J.M. Di Diego L. Belardinelli C. Antzelevitch Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation Circulation 108 2003 1027-1033
12. W. Shimizu C. Antzelevitch Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: Effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes Circulation 98 1998 2314-2322
13. L. Belardinelli C. Antzelevitch M.A. Vos Assessing predictors of drug-induced torsade de pointes Trends Pharmacol Sci 24 2003 619-625
14. S.H. Hohnloser T. Klingenheben B.N. Singh Amiodarone-associated proarrhythmic effects: A review with special reference to torsade de pointes tachycardia Ann Intern Med 1211994 529-535
15. M. Yamaguchi M. Shimizu H. Ino H. Terai K. Uchiyama K. Oe T. Mabuchi T. Konno T. Kaneda H. Mabuchi T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: A new index for arrhythmogenicity Clin Sci (Lond) 105 2003 671-676